Abound Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.8K | Sell |
44
-6
| -12% | -$2.43K | 0.01% | 349 |
|
|
2025
Q1 | $24.9K | Sell |
50
-14
| -22% | -$6.97K | 0.01% | 266 |
|
|
2024
Q4 | $33.4K | Sell |
64
-3
| -4% | -$1.57K | 0.01% | 219 |
|
|
2024
Q3 | $41.4K | Hold |
67
| – | – | 0.01% | 201 |
|
|
2024
Q2 | $37K | Buy |
67
+1
| +2% | +$552 | 0.01% | 184 |
|
|
2024
Q1 | $38.3K | Buy |
66
+7
| +12% | +$4.06K | 0.01% | 172 |
|
|
2023
Q4 | $31.4K | Sell |
59
-7
| -11% | -$3.72K | 0.01% | 198 |
|
|
2023
Q3 | $33.4K | Sell |
66
-4
| -6% | -$2.03K | 0.01% | 169 |
|
|
2023
Q2 | $36.5K | Buy |
70
+17
| +32% | +$8.87K | 0.02% | 161 |
|
|
2023
Q1 | $30.6K | Buy |
53
+11
| +26% | +$6.34K | 0.01% | 166 |
|
|
2022
Q4 | $23.1K | Buy |
42
+3
| +8% | +$1.65K | 0.01% | 174 |
|
|
2022
Q3 | $19.8K | Buy |
+39
| New | +$19.8K | 0.01% | 189 |
|